Allergy diagnostic market is estimated to be over US$ 3 bn in 2018. It is anticipated to grow at a CAGR of 9.8% from 2019 to 2030.
The continual growth of the allergy diagnostics market can be attributed to several factors which have led to wide scale adoption of these products which are extensively used to improve health of patients. Moreover, the growing demand for allergy diagnostics across the globe is anticipated to further contribute to the substantial growth of this market between 2019 and 2030. The market is driven by high incidence of allergic diseases and increasing pollution in environment. However, the high price of the allergy diagnostics instruments can restrain the growth of overall market.
Major Key Players of the Allergy Diagnostics Market are:
Thermo Fisher Scientific Inc., Omega Diagnostics Group PLC, Hitachi Chemical Co., Ltd., R-Biopharm AG, Stallergenes Greer, Siemens AG, Danaher Corporation, Biomérieux SA, Hycor Biomedical, Inc., Lincoln Diagnostics, Inc. among others.
No comments:
Post a Comment